CFO exercised or converted 61 IDXX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 14, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 18, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000874716-26-000018
Filed / recordedFeb 18, 2026, 12:30 AM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerIDEXX LABORATORIES INC /DE Reporting personAndrew Emerson Officer titleEVP, CFO and Treasurer TableNon-derivative (Table I) Transaction dateFeb 14, 2026 Acquired / disposedAcquired (A) Shares owned after3,950.444 Footnotes from the filing
- Includes a total of 18.666 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025 and December 31, 2025.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.